Synovis Life Technologies
Corporate Overview
Featured Report
DateTitle
01/12/11
Download Documentation 2010 Annual Report
Get help downloading or viewing the above file types
Corporate Profile

On February 14, 2012, Baxter International Inc. completed its planned acqusition of Synovis Life Technologies, Inc. The acqusition expands Baxter’s regenerative medicine and BioSurgery franchise by adding biological and mechanical products from Synovis used for soft tissue repair and microsurgery in a variety of surgical procedures. For more information, please visit www.baxterbiosurgery.com.

Recent NewsMore >>
DateTitle
12/14/11Synovis Life Technologies Reports 22 Percent Revenue Increase and Earnings Per Share of $0.24 in Fiscal 2011 Fourth Quarter
Diversified Product Portfolio Lifts Revenue 20 Percent and Net Income 74 Percent for Full Fiscal Year ST. PAUL, Minn.--(BUSINESS WIRE)--Dec. 14, 2011-- Synovis Life Technologies, Inc. (Nasdaq: SYNO), today reported its financial results for the fourth quarter and fiscal year ended October 31, 2011. Yesterday, Synovis and Baxter International Inc., (NYSE:BAX) announced a definitive agreement for Baxter to acquire Synovis. The Synovis board of directors has unanimously approved the transaction... 
12/13/11Baxter Signs Definitive Agreement to Acquire Synovis
DEERFIELD, Ill. & ST. PAUL, Minn.--(BUSINESS WIRE)--Dec. 13, 2011-- Baxter International Inc. (NYSE:BAX) and Synovis Life Technologies, Inc. (NASDAQ:SYNO) today announced a definitive agreement for Baxter to acquire Synovis, a leading provider of biological and mechanical products for soft tissue repair used in a variety of surgical procedures. The acquisition complements and will expand the portfolio of Baxter’s regenerative medicine and biosurgery franchise, which includes a number of devi... 
11/28/11Synovis Life Technologies, Inc. Fourth-Quarter and Full-Year Conference Call
Wednesday, Dec. 14, 2011, at 10 a.m. CT Synovis Life Technologies, Inc., (NASDAQ: SYNO) invites you to participate in a conference call with President and Chief Executive Officer Richard Kramp and Chief Financial Officer Brett Reynolds, who will discuss the company’s results for its fiscal fourth quarter and full year ended Oct. 31, 2011. The company will issue a pre-market earnings release on Wednesday, Dec. 14, 2011.   WHEN: 10 a.m. CT (11 a.m. ET) Wednesda... 
10/20/11Synovis Life Technologies Ranked in Deloitte Technology Fast 500(TM)
ST. PAUL, Minn., Oct 20, 2011 (BUSINESS WIRE) -- Synovis Life Technologies, Inc. (Nasdaq: SYNO) today announced its inclusion on Deloitte's 2011 Technology Fast 500(TM) list. The list ranks the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Synovis earned its ranking at No. 479 after attaining 147 percent revenue growth from fiscal 2006 to fiscal 2010. Synovis chief executive officer Richard Kramp credits the revenue gr... 

Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | Financial Tear Sheet Financial Tear Sheet
©2009 Copyright Synovis Surgical Innovations. All rights reserved. Privacy.